528 related articles for article (PubMed ID: 11114728)
1. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
2. Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells.
Sapi E; Flick MB; Rodov S; Kacinski BM
Cancer Res; 1998 Mar; 58(5):1027-33. PubMed ID: 9500466
[TBL] [Abstract][Full Text] [Related]
3. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
4. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
[TBL] [Abstract][Full Text] [Related]
5. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
6. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
7. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
9. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
10. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
[TBL] [Abstract][Full Text] [Related]
11. ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A.
Wen SC; Ku DH; De Luca A; Claudio PP; Giordano A; Calabretta B
Exp Cell Res; 1995 Mar; 217(1):8-14. PubMed ID: 7867724
[TBL] [Abstract][Full Text] [Related]
12. Induction of ETS-1 and ETS-2 transcription factors is required for thyroid cell transformation.
de Nigris F; Mega T; Berger N; Barone MV; Santoro M; Viglietto G; Verde P; Fusco A
Cancer Res; 2001 Mar; 61(5):2267-75. PubMed ID: 11280797
[TBL] [Abstract][Full Text] [Related]
13. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
O'Brien V; Campo MS
Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth.
Hahne JC; Okuducu AF; Kaminski A; Florin A; Soncin F; Wernert N
Oncogene; 2005 Aug; 24(34):5384-8. PubMed ID: 15940256
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells.
Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB
Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679
[TBL] [Abstract][Full Text] [Related]
18. Regulation of myeloid cell growth by distinct effectors of Ras.
Matsuguchi T; Kraft AS
Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction and the Ets family of transcription factors.
Yordy JS; Muise-Helmericks RC
Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
[TBL] [Abstract][Full Text] [Related]
20. Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro.
Hevér A; Oshima RG; Hauser CA
Exp Cell Res; 2003 Oct; 290(1):132-43. PubMed ID: 14516794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
